CIK 0001093557
- Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330857544
- Phone
- +1 858-200-0200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- 4 Grant or award Director acquired 1,054 shares (grant or award)
- 4 Grant or award Director acquired 918 shares (grant or award)
- 4 Grant or award Director acquired 910 shares (grant or award)
- 4 Grant or award Director acquired 918 shares (grant or award)
- 4 Grant or award Director acquired 910 shares (grant or award)
- 4 Open-market sale Chairman, CEO & President sold 5,535 shares at an average $379.88 ($2,102,626)
- 4 Open-market sale EVP, Chief Legal Officer sold 500 shares at $415.83 ($207,915)
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $410.31 ($442,727)
- 4 Open-market sale EVP, Global Revenue sold 758 shares at $400.00 ($303,200)
- 4 Open-market sale Chairman, CEO & President sold 6,221 shares at an average $366.67 ($2,281,082)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Chief Legal Officer sold 500 shares at $350.00 ($175,000)
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $360.49 ($388,967)
- 4 Open-market sale EVP Chief Commercial Officer sold 1,109 shares at an average $360.49 ($399,788)
- 4 Open-market sale SVP, Finance & CAO sold 941 shares at $362.92 ($341,505)
- 4 Open-market sale SVP Information Technology sold 4,567 shares at an average $360.03 ($1,644,267)
- 4 Open-market sale Chairman, CEO & President sold 14,044 shares at $362.92 ($5,096,806)
- 4 Open-market sale EVP Strategy and Corporate Dev sold 5,566 shares at $362.92 ($2,019,996)
Page 21 of 93 · 1,848 filings